Published on
Last updated on
Marketing Authorization Holder (MAH)
From 01.01.2020, every products must have a Marketing Authorization Holder (MAH), which is responsible for the entire supply chain, including the production and distribution of the product.This information is misleading. In China, the MAH is the manufacturer himself. The foreign manufacturer/MAH must authorize a legal representative in China as his NMPA Legal Agent.
Related News
New NMPA Guideline Defines Registration Requirements for IVUS Systems and Catheters
China’s CMDE releases a new IVUS registration review guideline, defining technical, clinical, and testing requirements for NMPA medical device registration
Malaysia Introduces New e-IFU & Digital Labelling Guidance for Medical Devices
Malaysia’s MDA publishes the 7th edition of guidance on medical device labelling, with new e-labelling, e-IFU, and accessibility requirements
Vietnam Authorities Step Up Cosmetic Recalls as Enforcement Tightens
Vietnam’s Drug Administration (DAV) is stepping up cosmetic product recalls as post-market surveillance tightens.